Engineers Gate Manager’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Engineers Gate Manager's TXG Position: Q2 2026 in Review
Engineers Gate Manager reduced its 10x Genomics (TXG) stake by 36% in Q2 2026, selling an estimated $872K and leaving 59,229 shares worth $2.27M. The position accounts for 0.03% of the portfolio, ranked #629.
Engineers Gate Manager first reported a position in TXG in Q1 2020 and has held it in 14 quarters since. The position peaked at $3.21M in Q1 2022. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- Engineers Gate Manager held 59,229 shares of 10x Genomics worth $2.27M as of Q2 2026.
- Engineers Gate Manager sold 33,284 10x Genomics shares in Q2 2026, an estimated $872K.
- 10x Genomics made up 0.03% of Engineers Gate Manager's portfolio in Q2 2026, its #629 holding.
- Engineers Gate Manager first reported a position in 10x Genomics in Q1 2020 and has held it in 14 quarters since.
- Engineers Gate Manager's 10x Genomics position peaked at $3.21M in Q1 2022.
- 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.